ENDOCYTE INC 4
4 · ENDOCYTE INC · Filed Feb 8, 2016
Insider Transaction Report
Form 4
ENDOCYTE INCECYT
Ellis P Ron
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2016-02-04$3.18/sh−3,320$10,558→ 333,036 total - Tax Payment
Common Stock
2016-02-06$3.02/sh−2,085$6,297→ 330,951 total - Award
Stock Option (right to buy)
2016-02-04+161,250→ 161,250 totalExercise: $3.18Exp: 2026-02-04→ Common Stock (161,250 underlying) - Award
Common Stock
2016-02-04+26,875→ 336,356 total
Footnotes (5)
- [F1]Represents restricted stock units that will vest and be paid 1/4 annually over a period of 4 years beginning on February 4, 2017, in the form of one share of common stock for each restricted stock unit.
- [F2]Includes 2,617 and 1,668 shares acquired under the Endocyte, Inc. 2010 Employee Stock Purchase Plan on June 15, 2015 and December 15, 2015, respectively.
- [F3]Represents shares withheld to satisfy tax withholding obligations associated with the settlement of 8,959 restricted stock units in the form of Company common stock on a one-for-one basis on February 4, 2016.
- [F4]Represents shares withheld to satisfy tax withholding obligations associated with the settlement of 5,625 restricted stock units in the form of Company common stock on a one-for-one basis on February 6, 2016.
- [F5]Shares subject to the option vest 1/4 annually over a period of 4 years beginning on February 4, 2017.